Adial Pharmaceuticals Inc
(ADIL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,751 | 2,827 | 4,002 | 6,062 | 4,401 |
| Other current assets | 0 | 0 | 429 | 0 | 0 |
| TOTAL | $4,059 | $3,199 | $4,780 | $6,462 | $5,136 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 58 | N/A |
| Investments And Advances | 982 | 1,534 | 0 | 0 | 0 |
| Intangibles | 3 | 4 | 5 | 254 | 6 |
| Other Non-Current Assets | 0 | 0 | 948 | 701 | 350 |
| TOTAL | $985 | $1,538 | $953 | $1,013 | $356 |
| Total Assets | $5,044 | $4,737 | $5,733 | $7,475 | $5,491 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 298 | 127 | 276 | 286 | 649 |
| Accrued Expenses | 678 | 478 | 963 | 2,377 | 857 |
| Other current liabilities | N/A | N/A | 10 | 10 | N/A |
| TOTAL | $976 | $653 | $1,791 | $2,722 | $1,505 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 665 | 1,221 | 0 |
| TOTAL | $N/A | $N/A | $665 | $1,245 | $N/A |
| Total Liabilities | $976 | $653 | $2,456 | $3,967 | $1,505 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,575 | 4,055 | 1,141 | 949 | 691 |
| Common Shares | 7 | 2 | 1 | 21 | 14 |
| Retained earnings | -81,995 | -68,798 | -63,675 | -50,943 | -31,520 |
| TOTAL | $4,068 | $4,084 | $3,277 | $3,508 | $3,986 |
| Total Liabilities And Equity | $5,044 | $4,737 | $5,733 | $7,475 | $5,492 |